Accomplished scientific leader with expertise within the pharmaceutical and biotechnology industries, with both strategic and tactical experience in driving innovation, leading cross-functional teams, and delivering impactful solutions in research and development. Adept at steering teams through R&D progression from early target and biomarker discovery/validation to bench-to-bedside translational strategies. Diagnostic assay development for use in clinical trials and driving strategic and tactical research initiatives in the discovery and translational space concurrently across diverse oncology drug programs. Contributed to the development and approval of Velcade®, Ninlaro®, and multiple programs (15+) in pre-clinical and clinical development across several drug modalities including small and large molecule inhibitors of oncogenic pathways, antibody drug conjugates, and cutting-edge immune-oncology strategies. Extensive experience in project management, including collaborating with Contract Research Organizations (CROs) and crafting Statements of Work (SOW) to effectively outsource tasks to optimize project efficiency and outcomes. Skilled at working across line functions to draft Master Service Agreements (MSAs) to ensure project compliance and mitigate risks. Accomplished histopathology Laboratory Director orchestrating strategic vision and day-to-day lab operations. Directing a team of bench scientists formatting assays to support target identification/validation, PD, and translational studies.
Listed skills include Antibody Drug Conjugates, Biomarkers, Pharmaceutical Industry, Translational Medicine, and 2 others.